CoChat

New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis

Open access
Ligresti, Alessia, Cascio, Maria Grazia, Pryce, Gareth, Kulasegram, Sanjitha, Beletskaya, Irina, De Petrocellis, Luciano, Saha, Bijali, Mahadevan, Anu, Visintin, Cristina, Wiley, Jenny L, Baker, David, Martin, Billy R, Razdan, Raj K, Di Marzo, Vincenzo · 2006 · British Journal of Pharmacology
Cited by 65

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

We previously reported that the compound O‐2093 is a selective inhibitor of the reuptake of the endocannabinoid anandamide (AEA). We have now re‐examined the activity of O‐2093 in vivo and synthesized four structural analogs (O‐2247, O‐2248, O‐3246, and O‐3262), whose activity was assessed in: (a) binding assays carried out with membranes from cells overexpressing the human CB 1 and CB 2 receptors; (b) assays of transient receptor potential of the vanilloid type‐1 (TRPV1) channel functional activity (measurement of [Ca 2+]i); (c) [14 C]AEA cellular uptake and hydrolysis assays in rat basophilic leukaemia (RBL‐2H3) cells; (d) the mouse ‘tetrad’ tests (analgesia on a hot plate, immobility on a ‘ring’, rectal hypothermia and hypolocomotion in an open field); and (e) the limb spasticity test in chronic relapsing experimental allergic encephalomyelitis (CREAE) mice, a model of multiple sclerosis (MS). O‐2093, either synthesized by us or commercially available, was inactive in the ‘tetrad’ up to a 20 mg kg−1 dose (i.v.). Like O‐2093, the other four compounds exhibited low affinity in CB 1 (Ki from 1.3 to >10 μM) and CB 2 binding assays (1.3<Ki< 8 μM), low potency and efficacy in a TRPV1 functional assay (EC 50>10 μM), very low potency as fatty acid amide hydrolase (FAAH) inhibitors (IC 50>25 μM) and were inactive in the ‘tetrad’ up to a 30 mg kg−1 dose (i.v.). While O‐2247 and O‐2248 were poor inhibitors of [14 C]AEA cellular uptake (IC 50>40 μM), O‐3246 and O‐3262 were quite potent in this assay. O‐3246, which exhibits only a very subtle structural difference with O‐2093, is the most potent inhibitor of AEA uptake reported in vitro under our experimental conditions (IC 50=1.4 μM) and is 12‐fold more potent than O‐2093. When injected intravenously O‐3246 and O‐3262, again like O‐2093 and unlike O‐2247 and O‐2248, significantly inhibited limb spasticity in mice with CREAE. These data confirm the potential utility of selective AEA uptake inhibitors as anti‐spasticity drugs in MS and, given the very subtle chemical differences between potent and weak inhibitors of uptake, support further the existence of a specific mechanism for this process. British Journal of Pharmacology (2006) 147, 83–91. doi:10.1038/sj.bjp.0706418

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0706418

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

Metadata

Authors
Ligresti, A., Cascio, M. G., Pryce, G., Kulasegram, S., Beletskaya, I., De Petrocellis, L., Saha, B., Mahadevan, A., Visintin, C., Wiley, J. L., Baker, D., Martin, B. R., Razdan, R. K., & Di Marzo, V.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2006-01
Volume
147
Issue
1
Pages
83-91
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2014266143
Cited by
65
References
9
FWCI
3.63
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.